Faculty Information - 守田　吉孝 |

（Last updated : 2021-03-03 10:07:03）

守田　吉孝
Department ,

Position

■ Journal

1.	2021/01	Certolizumab pegol-induced immunoglobulin A vasculitis in a patient with rheumatoid arthritis
2.	2020/12/23	Deletion of Mir223 exacerbates lupus nephritis by targeting S1pr1 in Faslpr/lpr mice
3.	2020/11/21	A tiger man: a case of muscular sarcoidosis
4.	2020/10/30	Inhibition of interleukin-6 signaling attenuates aortitis, left ventricular hypertrophy and arthritis in interleukin-1 receptor antagonist deficient mice
5.	2020/09/23	Tattoo skin reaction as a skin manifestation of systemic sarcoidosis
6.	2020/07/10	Severe oral stomatitis due to reactivation of herpes simplex virus type 1 in a methotrexate-treated patient with dermatomyositis.
7.	2020/06/10	Effect of Angiotensin II on Bone Erosion and Systemic Bone Loss in Mice with Tumor Necrosis Factor-Mediated Arthritis
8.	2020/03/30	In vivo analysis of thrombus formation in arthritic mice.
9.	2020/01	Aortitis which developed after the administration of granulocyte-colony stimulating factor.
10.	2019/10/31	Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should be Treated with Low-dose Prednisolone During Pembrolizumab Therapy
11.	2019/08	Functional analysis of a novel G87V TNFRSF1A mutation in patients with TNF receptor-associated periodic syndrome
12.	2019/07	Tuberculous fasciitis in a patient with systemic lupus erythematosus.
13.	2019/06	IL-6-PAD4 axis in the earliest phase of arthritis in knock-in gp130F759 mice, a model for rheumatoid arthritis
14.	2019/05	Infection of Helicobacter cinaedi Should be Treated for an Adequate Duration with Combined Antibiotic Therapy: Author's Reply.
15.	2019/04	Sh3bp2 Gain-Of-Function Mutation Ameliorates Lupus Phenotypes in B6.MRL-Faslpr Mice.
16.	2019/03	Japanese Spotted Fever: A Rare Cause of Arthritis
17.	2019/02/22	Tankyrase (PARP5) Inhibition Induces Bone Loss through Accumulation of Its Substrate SH3BP2.
18.	2019/01	Complete resolution of giant cell arteritis after tocilizumab monotherapy determined by positron emission tomography-CT
19.	2019	A case of intrauterine fetal death after thrombocytopenia in a patient with systemic lupus erythematosus and antiphospholipid syndrome
20.	2018/12	Bacteremia possibly caused by Helicobacter cinaedi and associated with painful erythema in rheumatoid arthritis with malignant lymphoma
21.	2018/10	Bladder carcinoma in situ in a patient with lupus cystitis
22.	2018/06	Scrub typhus (Tsutsugamushi disease) in a patient presenting with hemophagocytic syndrome
23.	2018/04	Treatment Update of Rheumatoid Arthritis
24.	2018/03	IgG4-related autoimmune pancreatitis complicated by splenic artery pseudoaneurysm.
25.	2018/03	Treatment of refractory rheumatoid pleural effusion with abatacept.
26.	2018/01	Chronic reactive arthritis associated with prostatitis caused by Neisseria meningitidis.
27.	2018/01	Mycophenolate mofetil treatment in a patient with recurrent lymphocytic hypophysitis.
28.	2018/01	Necrosis of the gastrocnemius muscle in microscopic polyangiitis.
29.	2018/01	Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis.
30.	2017/12	Nivolumab-induced polyarthritis
31.	2017/09	Successful treatment using rituximab in a patient with refractory polymyositis complicated by scleroderma renal crisis
32.	2017/08	POEMS syndrome in a patient with rheumatoid arthritis
33.	2015/12	Arthritis in a patient with Takayasu arteritis
34.	2015/12	Left ventricular mechanics and myocardial calcium dynamics in short-term and long-term hyperthyroid mice
35.	2015/12	TNF receptor type 2 transmits caspase-dependent apoptotic signals in fibroblast-like synoviocytes derived from rheumatoid arthritis
36.	2015/04	Development of aseptic subcutaneous abscess after tocilizumab therapy in a patient with SAPHO syndrome complicated by amyloid A amyloidosis
37.	2015/03	Loss of SH3 Domain-Binding Protein2 Function suppresses Bone Destruction in Tumor Necrosis Factor-Driven and Collagen-Induced Arthritis in Mice
38.	2014/12	Hospital and clinic cooperation for the treatment of rheumatoid arthritis in Okayama Prefecture, Japan
39.	2014/08	SH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis model
40.	2014/07	ACT-Ray study
41.	2013/10	Spontaneous splenic rupture complicating granulomatosis with polyangiitis (Wegener's)
42.	2013/08	Predominance of Th2 and regulatory cytokines in the serum of a patient with IgG4-related lymphadenopathy
43.	2013/07	Rituximab in rheumatoid arthritis
44.	2012/12	Immunosuppressive drugs in rheumatoid arthritis
45.	2012/12	Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling.
46.	2012/04	Mesenteric panniculitis: a rare cause of fever
47.	2012/04	Necrotizing fasciitis in a patient with rheumatoid arthritis treated with tocilizumab
48.	2010/05	Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers.
49.	2008	Abdominal pain as the initial presentation of Takayasu arteritis.
50.	2008	Co-occurrence of poststreptococcal reactive arthritis and acute glomerulonephritis.
51.	2008	Efficacy of low-dose tacrolimus added to methotrexate in patients with rheumatoid arthritis in Japan: a retrospective study.
52.	2007/06	Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis.
53.	2007	Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis.
54.	2007	Bilateral ureteral stenosis and duodenal perforation in patient with dermatomyositis.
55.	2006/09	Cardioprotective role of endogenous hydrogen peroxide during ischemia-reperfusion injury in canine coronary microcirculation in vivo
56.	2006/06	Endothelial dysfunction in rat adjuvant-induced arthritis: vascular superoxide production by NAD(P)H oxidase and uncoupled endothelial nitric oxide synthase.
57.	2006/02	[Molecular biology in regulation of kidney functions: Nitric oxide]
58.	2006	Hypokalemic paralysis and osteomalacia secondary to renal tubular acidosis in a case with primary Sjögren’s syndrome.
59.	2006	Hypokalemic paralysis and osteomalacia secondary to renal tubular acidosis in a case with primary Sjogren's syndrome
60.	2005/03	Multiple venous thrombosis in SAPHO syndrome.
61.	2005	A case of Vogt-Koyanagi-Harada disease that developed relapsing polychondritis.
62.	2005	Cytokine production by dendritic cells genetically engineered to express IL-4: induction of Th2 responses and differential regulation of IL-12 and IL-23 synthesis.
63.	2004/01	Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?
64.	2003/09	Xenogeneic cells and superantigen induce human T-cell activation in the absence of T-cell recognition of xenoantigen.
65.	2002	CD14+CD16+ blood monocytes and joint inflammation in rheumatoid arthritis.
66.	2002	Renal involvement in rheumatoid arthritis: analysis of renal biopsy specimens from 100 patients.
67.	2001	Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis.
68.	2001	Differential in vitro effects of IL-4, IL-10, and IL-13 on proinflammatory cytokine production and fibroblast proliferation in rheumatoid synovium.
69.	2001	Effector function of resting T cells: activation of synovial fibroblasts.
70.	2001	Effector function of resting T cells: activation of synovial fibroblasts.
71.	2001	Functional effects of new T cell panel antibodies and other workshop reagents on interactions between T lymphocytes and synovial fibroblasts.
72.	2001	Human Keratinocytes and synovial fibroblasts express a novel a CD6 ligand.
73.	2001	Interferon-γ-inducing activity of interleukin-18 in the joint with rheumatoid arthritis.
74.	2000	Efficacy of galectins in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats.
75.	1999	Fibroblast-like synoviocytes from patients with rheumatoid arthritis can produce interleukin-7 and interleukin-15.
76.	1998/02	Antisense oligonucleotides targeting c-fos mRNA inhibit rheumatoid synovial fibroblast proliferation.
77.	1998	Expression of interleukin-12 in synovial tissue from patients with rheumatoid arthritis.
78.	1998	Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis.
79.	1998	Increased type 2 cytokine expression by both CD4+CD45RO+ T cells and CD8+CD45RO+ T cells in blood circulation is associated with high levels of serum IgE in patients with atopic dermatitis.
80.	1997/10	Increased production of interleukin-10 and inflammatory cytokines in blood monocytes of hemodialysis patients.
81.	1997/07	Inhibition of rheumatoid synovial fibroblast proliferation by antisense oligonucleotides targeting proliferating cell nuclear antigen messenger RNA.
82.	1997	The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis.
83.	1996/07	Takayasu's arteritis associated with ulcerative colitis; genetic factors in this association
84.	1995	A case of methotrexate-induced acute renal failure successfully treated with plasma perfusion and sequential hemodialysis.
85.	1995	Inhibition of mesangial cell proliferation and matrix expansion by antisense oligonucleotides.
86.	1995	Sweet's syndrome associated with undifferentiated connective tissue syndrome.
87.	1994	Beneficial effect of low molecular weight heparin ("fragmin") on proteinuria of proliferative glomerulonephritis.
Display 5 items
Display all(87)

■ Presentation

1.	2020/12/04	The role of an adaptor protein SH3BP2 in the pathogenesis of systemic lupus erythematosus
2.	2020/12/02	Deletion of Mir223 Exacerbates Lupus Nephritis by Targeting S1pr1 in Fas lpr/lpr Mice
3.	2020/11/07	SH3BP2 Deciency Ameliorates Murine Systemic Lupus Erythematosus
4.	2020/11/05	Deletion of miR-223 exacerbates lupus nephritis by targeting S1pr1 in Faslpr/lpr mice
5.	2020/10/24	Deletion of miR-223 exacerbates lupus nephritis by targeting S1pr1 in Faslpr/lpr mice
6.	2020/10/24	Edit Effect of Angiotensin II on Bone Erosion and Systemic Bone Loss in Mice with Tumor Necrosis Factor-Mediated Arthritis
7.	2020/10/24	SH3BP2 deficiency ameliorates murine systemic lupus erythematosus
8.	2020/07/08	全身性エリテマトーデスモデルマウスにおけるアダプター蛋白SH3BP2 の自己免疫現象における役割の解明
9.	2019/11/10	The role of adopter protein SH3BP2 in a murine systemic lupus erythematosus model
10.	2019/11/10	The Study of the Novel G87V Mutation in the TNFRSF1A Gene Identified in a Family with TNF Receptor-Associated Periodic Syndrome (TRAPS)
11.	2019/05/14	Inhibition of Interleukin-6 Signaling on Aortitis in Interleukin-1 Receptor Antagonist Deficient Mice
12.	2019/04/17	SH3BP2 gain-of-function mutation ameliorates lupus in B6.MRL-Faslpr mice
13.	2019/04/16	The Study of the novel G58V mutation in the TNFRSF1A gene identified in a family with TNF Receptor-Associated Periodic Syndrome(TRAPS)
14.	2019/04/15	In vivo imaging of arterial thrombus formation in a murine arthritis model
15.	2018/10/21	The novel G58V mutation in the TNFRSF1A gene identified in a family with TNF Receptor-Associated Periodic Syndrome (TRAPS) decreases the cell surface expression of TNFR1
16.	2018/04/27	Bone systemic administration of angiotensin II and its type 1 receptor gene deletion exacerbates erosive bone destruction in hTNF-transgenic arthritis mice
17.	2018/04/27	Myostatin inhibition reduces bone loss in an unloading osteoporosis model
18.	2018/04/27	Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastgenesis
19.	2018/04/27	SH3BP2 gain-of-function mutation alleviates lupus phenotypes in B6.MRL-Faslpr mice
20.	2018/04/26	Functional analysis of the novel G58V mutation in the TNFRSF1A gene identified in a family with TNF receptor-associated periodic syndrome(TRAPS)
21.	2017/11/07	SH3BP2 Gain-of-Function Mutation Ameliorates Lupus in B6.MRL-Faslpr Mice
22.	2017/11/06	Angiotensin II Type I Receptor Deficiency Exacerbates Erosive Bone Destruction ofhTNF-Transgenic Arthritis Mice
23.	2017/11/05	Functional Analysis of the Novel G58V Mutation in the TNFRSF1A Gene Identified in a Family with TNF Receptor-Associated Periodic Syndrome (TRAPS)
24.	2017/11/05	Tankyrase/Wnt Inhibitor Upregulates Osteoclastogenesis and Osteoblastogenesis Via SH3BP2
25.	2017/11/05	The Effect of Myostatin Inhibition on Bone Loss in Murine Osteoporosis Models
26.	2017/04/21	Tankyrase regulates bone mass and osteoclastogenesis
27.	2017/04/20	Angiotensin II exacerbates bone destruction in human TNF-transgenic arthritis mice
28.	2017/04/20	The effect of myostatin inhibition on bone loss in murine osteoporosis models
29.	2016/11/14	Tankyrase Regulates Osteoclastogenesis Via SH3BP2
30.	2016/11/13	Angiotensin II Exacerbates Bone Destruction in TNF-Transgenic Arthritis Mice
31.	2016/04/23	Tankyrase Inhibitor Promotes Osteoclastogenesis by Enhancing SH3BP2 expression
32.	2015/11/16	Tankyrase regulates osteoclastogenesis via SH3BP2 expression
33.	2015/11/08	Tankyrase regulates osteoclastogenesis via SH3BP2 expression
34.	2013/10/05	SH3BP2 "Cherubism" Gain-of-Function Mutation Exacerbates Inflammation and Bone Erosion in Murine Collagen-Induced Arthritis Model
35.	2009/06/12	Role of renin-angiotensin system activation in the development of vascular damages in rat adjuvant-induced arthritis: effect of angiotensin receptor blockers
36.	2008/09/23	Systemic inflammation in rat arthritis model potentiates hypertensive and vascular hypertrophic responses to angiotensin II
37.	2007/04/26	A case of systemic lupus erythematosus accompanying Epstein-Barr virus reactivation
38.	2007/04/26	Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis
39.	2005/11/08	Implication of Senescence Associated Klotho Gene in the Pathogenesis of Progressive Renal Injuries.
40.	2005/11/08	Role of Reactive Oxygen Species (ROS) and Nitric Oxide (NO) in Hypertrophy in the Kidney after Uninephrectomy.
41.	2005	Infliximab improves serum adiponectin levels and endothelial dysfunction in patients with rheumatoid arthritis
42.	2002	Cytokine production by dendritic cells genetically engineered to express IL-4: induction of Th2 responses and differential regulation of IL-12 and IL-23
43.	2000	Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis.
44.	2000	Effector function of resting T cells: activation of synovial fibroblasts.
45.	2000	Functional effects of new T cell panel antibodies and other workshop reagents on interactions between T lymphocytes and synovial fibroblasts.
46.	2000	Human Keratinocytes and synovial fibroblasts express a novel a CD6 ligand.
47.	1999	Rheumatoid arthritis synovial fibroblasts express a novel a CD6 ligand.
48.	1998	CD16+ blood monocytes are increased in active patients with rheumatoid arthritis.
49.	1998	Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis.
50.	1998	Highly elevated levels of serum interleukin-18 in adult onset still’s disease.
51.	1997	Increased production of interleukin-18 in synovium from patients with rheumatoid arthritis.
52.	1996	A role of interleukin-12 in perpetuating Th1 cell-mediated immune responses in rheumatoid arthritis.
53.	1996	Elevated levels of IFN--inducing factor in synovial fluid of patients with rheumatoid arthritis.
54.	1996	Fibroblast-derived mediators of T cell expansion in rheumatoid arthritis include interleukin-7 and interleukin-15.
55.	1995	Anti-inflammatory properties of interleukin-13 in rheumatoid synovial inflammation
56.	1995	Constitutive activation of NF-B in rheumatoid synovium.
57.	1995	Interleukin-7 production by rheumatoid synovial fibroblasts.
58.	1995	The expression of interleukin-12 as an inducer of T helper type 1-specific immune responses in rheumatoid synovitis.
59.	1994	Differential effects of interleukin-4 and interleukin-10 on rheumatoid synovial fibroblasts
60.	1994	Interleukin-10 expressed in synovial tissue modulates the cytokine profile of rheumatoid arthritis
Display 5 items
Display all(60)